General Information

Overview

Controlled ovarian stimulation (COS) now plays a major role in optimising IVF outcomes by facilitating control of different aspects of the process and increasing the number of oocytes available. COS aims to achieve maximal success with minimal side effects. Progress in and understanding of ovarian physiology, as well as new advances in ovarian stimulation strategies have made it possible for healthcare professionals to achieve the optimal outcomes for patients.

Success in assisted reproductive technology (ART) depends on carefully controlled conditions in every step of the laboratory routine. In addition, continuous advances in technology require constant revision of good laboratory practices and the introduction of new techniques. This educational activity will improve the participants’ knowledge of the latest technologies and laboratory practice guidelines.

The learning activity offers an interactive programme with specialised lectures tailored to fit the needs of physicians and embryologists working in ART, followed by lectures and case studies.

Learners will have the opportunity to discuss, directly with renowned scientists, pertinent topics that have been the subject of controversy and innovation.  Discussions will concentrate on how to facilitate optimal laboratory conditions, culture environments, selection criteria and how to select the best therapy for infertile patients.

Learning Objectives

After attending the educational activities, learners will be able to:

  • Define laboratory and clinical outcomes for defining success in ART
  • Key factors influencing the success of ART
  • Tailor the best stimulation protocol for patients undergoing ART
  • Discuss and debate changing approaches to ART

Target Audience

This programme is designed for clinicians and biologists working in assisted reproductive medicine, who want to acquire up-to date information for improving their current practice.

Chairs

Carlo Alviggi
Federico II University
Naples, Italy

Sandro C. Esteves
Androfert – Andrology and Human Reproduction Clinic
Campinas, Brazil

Robert Fischer
Fertility Centre Hamburg
Hamburg, Germany

Peter Humaidan
Fertility Clinic, Skive Regional Hospital
Faculty of Health, Aarhus University
Aarhus, Denmark

Accreditation

This medical education programme “Quality Standards and Innovation in Assisted Reproductive Technologies, Moscow, Russia, 19-20 June 2020” has been granted 11 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).

Venue

This live educational conference will take place at:

Skolkovo Innovation Center
Bolshoi blv., 46, bld. 1
Moscow Oblast 143005
Moscow, Russia

Registration

For registration, dinner, accommodation and any logistic inquiry, please contact:
Ivanova Mariya
reg@conferencemedicine.ru
Phone: +7 495 134 62 11

Or

EVENT PLANET SRL
Antonietta Faciano
antonietta.falciano@eventplanetgroup.com
Phone: +39 377 097 0640
www.eventplanetgroup.com

Registration fee
Live streaming:
15 000 RUB / 210 EUR

Early bird registration up to 15 February:
18 900 RUB /270 EUR

Late registration from 16 February:
24 500 RUB / 350 EUR

The registration fee includes:

  • Access to scientific sessions
  • Educational materials
  • Certificate of attendance
  • Coffee breaks and luncheons

Dinners are not included.

Language

The official language of this live educational conference will be English
Simultaneous translation from English to Russian and vice versa will be provided.

CME Provider

Med.E.A – Medical Education Academy
Chloe Xilinas: Programme and Relations Manager in Medical Education
chloe.xilinas@medea.academy

Preliminary Programme

Final Programme

Faculty

alviggi

Carlo Alviggi

Naples, Italy

fisher-small

Robert Fischer

Hamburg, Germany

Baukloh-small

Vera Baukloh

Hamburg, Germany

humaidan-small

Peter Humaidan

Aarhus, Denmark

Capalbo-small

Antonio Capalbo

Rome, Italy

La-Marca-small

Antonio La Marca

Modena, Italy

conforti-small

Alessandro Conforti

Naples, Italy

meseguer-small

Marcos Meseguer

Valencia, Spain

esteves-small

Sandro C. Esteves

Campinas, Brazil

F_Ubaldi

Filippo M. Ubaldi

Rome, Italy

igor-small

Igor Ivanov

Moscow, Russia

zorina-small

Irina Zorina

Moscow, Russia

Scientific Programme

Friday, 19 March 2021

08.00

Registration

09.00

Introduction
R. Fischer, Germany

09.05

Welcome opening
I. Zorina, Russia

Session I

Chair: R. Fischer, Germany

09.15

L1 – What is success in ART?
F.M. Ubaldi, Italy

09.40

Questions
F.M. Ubaldi, Italy

09.45

L2 – The relevance of a QMS in ART clinic and labotaory
V. Baukloh, Germany

10.10

Questions
V. Baukloh, Germany

10.15

L3 – Necessity of a QMS in ART for practical doctor
I. Ivanov, Russia

10.35

Panel discussion

11.05

Coffee break

11.25

L4 – How to define subgroups for COS and role of oocyte number
A. La Marca, Italy

11.50

Questions
A. La Marca, Italy

11.55

L5 – The role of polymorphisms of gonadotrophins and their receptors in COS
A. Conforti, Italy

12.20

Questions
A. Conforti, Italy

12.25

L6 – Characteristics of polymorphisms of gonadotrophin receptors in patients undergoing ART treatment
I. Zorina, Russia

12.40

Panel discussion

13.10

Lunch

Session II

Chairs: S.C. Esteves, Brazil – R. Fischer, Germany

14.30

L7 – From poor response to low prognosis: The POSEIDON concept
C. Alviggi, Italy

14.55

Questions
C. Alviggi, Italy

15.00

L8 – The ART Calculator and its role in the Patient´s management
S. Esteves, Brazil

15.25

Questions
S. Esteves, Brazil

15.30

Panel discussion

16.00

End of the first day

Saturday, 20 March 2021

Chairs: S.C. Esteves, Brazil – R. Fischer, Germany

9.00

L9 – The Management of Poseidon Group 1&2
C. Alviggi, Italy

09.25

Questions
C. Alviggi, Italy

09.30

L10 – The Management of Poseidon Group 3&4
P. Humaidan, Denmark

09.55

Questions
P. Humaidan, Denmark

10.00

L11 – Ovulation – triggering strategies and the adequate Luteal Phase support
P. Humaidan, Denmark

10.25

Questions
P. Humaidan, Denmark

10.30

Panel discussion

11.00

Coffee break

Session III

Chairs: R. Fischer, Germany – P. Humaidan, Denmark

11.20

L12 – The role of recent advancement in laboratory technology to improve ART outcome (Time Lapse; Vitrification)
M. Meseguer, Spain

11.45

Questions
M. Meseguer, Spain

11.50

L13 – The role of pre-implantation testing for aneuploidy to improve selection. What are the limits?
A. Capalbo, Italy

12.15

Questions
A. Capalbo, Italy

12.20

Panel discussion

12.45

Lunch

Session IV

Chair: C. Alviggi, Italy – R. Fischer, Germany

14.00

L14 – The influence of the microbiota of the endometrium and the reproductive tract on the outcomes of ART
P. Humaidan, Denmark

14.25

Questions
P. Humaidan, Denmark

14.30

L15 – The importance of the andrology and sperm evaluation aspects in ART outcome
S. Esteves, Brazil

14.55

Questions
S. Esteves, Brazil

15.00

L16 – A quality management approach to COS-The Fischer Protocol
R. Fischer, Germany

15.20

Questions
R. Fischer, Germany

15.30

L17 – Is the time ready for “freeze-all” strategy for all patients? What is the best frozen embryo transfer protocol?
F.M. Ubaldi, Italy

15.55

Questions
F.M. Ubaldi, Italy

16.00

Panel discussion

16.30

Concluding remarks and coffee

Funding

Med.E.A Srl educational programmes are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products. These views are the responsibility of the named speakers, and do not represent an endorsement or recommendation on the part of Med.E.A. Srl. This independent programme is made possible thanks to an educational grant received from Reproductive Medicine Agency (Nova Clinic).

 

And sponsors of the exhibition area: